Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.

British journal of cancer - 26 Jan 2004

Boland G P, Butt I S, Prasad R, Knox W F, Bundred N J

Abstract excerpt

Cyclooxygenase type-2 (COX-2) is overexpressed in malignant tumours including breast cancers, though the mechanism of upregulation is unclear. This study aimed to determine COX-2 expression in ductal carcinoma in situ (DCIS) in comparison to invasive breast cancer (IBC) and normal breast, and als...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Intraductal, Noninfiltrating
Share to Cyclooxygenase 2
Share to Cyclooxygenase 2 Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclooxygenase Inhibitors

Share to Isoenzymes

Share to Neoplasm Invasiveness

Share to Prostaglandin-Endoperoxide Synthases

Share to Receptors, Estrogen

Source

Open in PubMed Open full text

Identifiers

PMID: 14735188
DOI: 10.1038/sj.bjc.6601534
PMCID: PMC2409574

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14735188-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.PMID 14735188Read ↗

Immunohistochemical COX-2 overexpression correlates with HER-2/neu overexpression in invasive breast carcinomas: a pilot study.Semantic proximity Read ↗

Is Cyclooxygenase 2 Effective in Breast Cancer Diagnosis?Semantic proximity Read ↗

Identifying progression predictors of breast ductal carcinoma in situSemantic proximity Read ↗

Cyclooxygenase-2 gene expression in human breast cancerSemantic proximity Read ↗

Overexpression of Cyclooxygenase-2 Is Associated with a Favorable Prognostic Phenotype in Breast CarcinomaSemantic proximity Read ↗

S-Nitrosylated COX-2 is a TME-regulated breast cancer biomarker of mesenchymal phenotypesSemantic proximity Read ↗

Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity.Semantic proximity Read ↗

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.Semantic proximity Read ↗

Cyclooxygenase‐2 modulates cellular growth and promotes tumorigenesisSemantic proximity Read ↗

Role of Cyclooxygenase-2 in Head and Neck Tumorigenesis.Semantic proximity Read ↗

Potential biomarkers of ductal carcinoma in situ progressionSemantic proximity Read ↗

[Cyclooxygenase 2 and carcinogenesis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.